Bauer Claus-Jürgen, Skowasch Dirk, Kreuter Michael, Hamer Okka W, Behr Jürgen, Gläser Sven, Heussel Claus Peter, Kütting Daniel, Krause Andreas, Leuschner Gabriela, Markart Philipp, Petzinna Simon Michael, Polke Markus, Schäfer Valentin Sebastian
Medizinische Klinik III für Onkologie, Hämatologie, Zell- und Immuntherapien, Klinische Immunologie und Rheumatologie, Universitätsklinikum Bonn, Bonn, Deutschland.
Medizinische Klinik und Poliklinik II, Sektion Pneumologie, Universitätsklinikum Bonn, Bonn, Deutschland.
Z Rheumatol. 2025 Aug 7. doi: 10.1007/s00393-025-01660-w.
Interstitial lung diseases (ILD) represent an interdisciplinary clinical challenge and are not uncommonly associated with rheumatological diseases. Interstitial lung disease multidisciplinary meetings (ILD-MDM) provide a structured platform for interdisciplinary case discussions and decision making. Despite their great importance in patient care, data on the prevalence, structure and function of ILD-MDM in Germany are lacking.
The aim of the study was to assess the current status of ILD-MDM in German hospitals to gain insights into their composition, processes and potential for optimization.
A web-based survey was conducted via SurveyMonkey under the auspices of the German Society for Rheumatology and Clinical Immunology (DGRh) and in collaboration with the German Respiratory Society (DGP) and the German Radiological Society (DRG). A standardized questionnaire captured information on the participating specialist disciplines, organizational structures as well as the content and challenges of local ILD-MDM. The analysis was conducted descriptively.
A total of 125 physicians from 15 federal states in Germany participated. Pulmonologists (93.6%), radiologists (86.4%), rheumatologists (59.2%) and pathologists (57.6%) are the most commonly represented members of ILD-MDM. The majority of ILD-MDMs are conducted either in person (50%) or in a hybrid format (31.5%) and are held on a weekly basis (41.1%). Of all patient cases discussed, two thirds receive a definitive diagnosis and treatment recommendation.
The findings reveal a high acceptance and prevalence of ILD-MDM in Germany but also highlight potential areas for improvement, particularly regarding interdisciplinary participation, technical infrastructure and standardization.
间质性肺疾病（ILD）是一项跨学科的临床挑战，且常与风湿性疾病相关。间质性肺疾病多学科会议（ILD-MDM）为跨学科病例讨论和决策提供了一个结构化平台。尽管它们在患者护理中非常重要，但德国关于ILD-MDM的患病率、结构和功能的数据却很缺乏。
本研究的目的是评估德国医院中ILD-MDM的现状，以深入了解其组成、流程和优化潜力。
在德国风湿病与临床免疫学协会（DGRh）的支持下，通过SurveyMonkey进行了一项基于网络的调查，并与德国呼吸学会（DGP）和德国放射学会（DRG）合作。一份标准化问卷收集了有关参与的专业学科、组织结构以及当地ILD-MDM的内容和挑战的信息。分析采用描述性方法。
德国15个联邦州的125名医生参与了调查。肺科医生（93.6%）、放射科医生（86.4%）、风湿科医生（59.2%）和病理科医生（57.6%）是ILD-MDM中最常见的成员。大多数ILD-MDM以面对面形式（50%）或混合形式（31.5%）进行，且每周举行一次（41.1%）。在所有讨论的患者病例中，三分之二获得了明确的诊断和治疗建议。
研究结果显示ILD-MDM在德国具有较高的接受度和患病率，但也突出了潜在的改进领域，特别是在跨学科参与、技术基础设施和标准化方面。
